Toxoplasma chorioretinitis
ICD-10 B55.2 is a billable code used to indicate a diagnosis of toxoplasma chorioretinitis.
Toxoplasma chorioretinitis is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause severe complications in immunocompromised individuals, particularly those with HIV/AIDS. The condition is characterized by inflammation of the choroid and retina, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. Toxoplasmosis is often acquired through ingestion of oocysts found in contaminated food or water, or through vertical transmission from mother to fetus during pregnancy. Diagnosis typically involves clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as fundus photography or optical coherence tomography (OCT). Treatment usually includes antiparasitic medications such as pyrimethamine and sulfadiazine, often combined with leucovorin to mitigate side effects. Early diagnosis and treatment are crucial to prevent irreversible damage to the retina and preserve vision.
Detailed ocular examination findings, imaging results, and treatment plans.
Patients presenting with vision changes, floaters, or ocular pain.
Ensure documentation reflects the severity of the condition and any associated systemic symptoms.
Comprehensive patient history, serological test results, and treatment regimens.
Immunocompromised patients with suspected or confirmed Toxoplasma infection.
Document any co-infections and the patient's immune status to support coding.
Used when a new patient presents with symptoms of chorioretinitis.
Document the patient's history, symptoms, and examination findings.
Ophthalmologists should ensure thorough documentation of visual acuity and fundoscopic findings.
Common symptoms include blurred vision, floaters, and in severe cases, vision loss. Patients may also experience ocular pain and redness.
